Structural and functional characterization of human immunodeficiency virus tat protein
about
The mechanism of release of P-TEFb and HEXIM1 from the 7SK snRNP by viral and cellular activators includes a conformational change in 7SKDirect interaction of the human I-mfa domain-containing protein, HIC, with HIV-1 Tat results in cytoplasmic sequestration and control of Tat activityThe type 1 human immunodeficiency virus Tat binding protein is a transcriptional activator belonging to an additional family of evolutionarily conserved genesSp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat proteinInhibition of HIV-1 Tat-mediated LTR transactivation and HIV-1 infection by anti-Tat single chain intrabodiesCrystal structure of HIV-1 Tat complexed with human P-TEFbRegulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factorsIdentification of sequences important in the nucleolar localization of human immunodeficiency virus Rev: relevance of nucleolar localization to functionMutational analysis of the conserved basic domain of human immunodeficiency virus tat proteinInteractions of thyroid hormone receptor with the human immunodeficiency virus type 1 (HIV-1) long terminal repeat and the HIV-1 Tat transactivatorInhibition of HIV derived lentiviral production by TAR RNA binding domain of TAT protein.The Startling Properties of Fibroblast Growth Factor 2: How to Exit Mammalian Cells without a Signal Peptide at HandA novel human immunodeficiency virus type 1 protein, tev, shares sequences with tat, env, and rev proteinsPotent inhibition of HIV-1 replication by a Tat mutant.A novel glutamine-RNA interaction identified by screening libraries in mammalian cells.Random mutagenesis of the human immunodeficiency virus type-1 trans-activator of transcription (HIV-1 Tat).Selection of TAR RNA-binding chameleon peptides by using a retroviral replication system.The HIV Tat protein affects processing of ribosomal RNA precursor.Nuclear factor-kappa B family member RelB inhibits human immunodeficiency virus-1 Tat-induced tumor necrosis factor-alpha production.A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat.A simple optogenetic MAPK inhibitor design reveals resonance between transcription-regulating circuitry and temporally-encoded inputs.Phenotype-associated env gene variation among eight related human immunodeficiency virus type 1 clones: evidence for in vivo recombination and determinants of cytotropism outside the V3 domain.Modulation of Sp1 phosphorylation by human immunodeficiency virus type 1 Tat.Activity of synthetic tat peptides in human immunodeficiency virus type 1 long terminal repeat-promoted transcription in a cell-free system.Conjugation to the cell-penetrating peptide TAT potentiates the photodynamic effect of carboxytetramethylrhodamine.Human immunodeficiency virus Tat associates with a specific set of cellular RNAsSequence-specific interaction of Tat protein and Tat peptides with the transactivation-responsive sequence element of human immunodeficiency virus type 1 in vitro.Cloning and characterization of cDNAs encoding equine infectious anemia virus tat and putative Rev proteins.Inhibition of human immunodeficiency virus type 1 Tat activity by coexpression of heterologous trans activators.The basic domain of HIV-tat transactivating protein is essential for its targeting to lipid rafts and regulating fibroblast growth factor-2 signaling in podocytes isolated from children with HIV-1-associated nephropathy.Activity of synthetic peptides from the Tat protein of human immunodeficiency virus type 1A nucleolar TAR decoy inhibitor of HIV-1 replication.Characterization of Tat antibody responses in Chinese individuals infected with HIV-1.Novel multi-component nanopharmaceuticals derived from poly(ethylene) glycol, retro-inverso-Tat nonapeptide and saquinavir demonstrate combined anti-HIV effectsTat-neutralizing antibodies in vaccinated macaques.Development of HIV reservoir targeted long acting nanoformulated antiretroviral therapiesThe activation region of the Tat protein of human immunodeficiency virus type-1 functions in yeast.Exon2 of HIV-2 Tat contributes to transactivation of the HIV-2 LTR by increasing binding affinity to HIV-2 TAR RNA.The effect of N-acetylation and N-methylation of lysine residue of Tat peptide on its interaction with HIV-1 TAR RNA.Transactivation and signaling functions of Tat are not correlated: biological and immunological characterization of HIV-1 subtype-C Tat protein.
P2860
Q21136168-6741D439-50D1-4B20-BB88-EFE66968EA3DQ24293249-202575B7-8D5B-418E-9E8E-A0FE55F80BD3Q24319734-821586C5-E1CA-410D-96E1-AF37FA276C40Q24561778-44D11E58-7985-4F10-AA43-2496559B0B98Q24568329-AE9BCF2D-CEB8-4C58-86C7-F8B2E50A05DEQ24634569-357E4CD0-A3E5-455C-91CD-6F46F9D0E528Q24651506-5CC8AD9E-8C1E-4238-9998-635956EA4B6AQ24652587-F9E6CCE8-955C-4223-89EB-E92C440796DDQ24656004-2CC73218-5996-4931-9D8E-1A3467EDD182Q24671522-47505FFE-A702-48FA-9F6A-980D87A09D19Q24815731-F41B1137-F18E-4056-82AB-0BC5242B9F35Q28085435-3F787EF0-F8DF-432B-9C7A-8A0E49BAEFD2Q28246228-5AFFBED2-978A-43C6-9D4D-25AA63F10307Q30879123-C8E225B5-B3DF-41FB-B66F-15FA11400F08Q32068514-DA88A69F-2DA9-4FA5-8DC4-2F3A67B7729BQ33192810-FF58556B-B185-49FF-BE1B-A65F676D3391Q33196801-A711D0E9-3FE9-417F-B24C-8C22E2EB7687Q33344221-6B46899B-F7DE-4D3E-9967-FEE7B580D723Q33649838-47570C91-E25A-485A-BC0E-14F16F4F4C7EQ33662926-9369FA83-FEF6-430F-95D7-E589C29FC6D4Q33705703-EA7BAD55-FD8F-41DC-8185-FD61A46E1443Q33719811-DCFE78DC-CB50-4291-A022-7F8E1F14A6C1Q33782959-0E8353D9-8F2F-497A-8FB2-AE51613BB669Q33787595-AA3CB360-740E-4C9E-9BD3-608D465CD140Q33851793-55A3BAED-083C-496C-BD33-43DEDE875BA6Q33863026-6C628021-A436-4B78-ACD3-EE6433E3E7A1Q33900660-B4ACE94E-BE4C-4308-BF1A-9D110E05D2CAQ33924816-860ED3F5-805B-4313-B71C-302D14DAFF2DQ33930741-71A6632F-840D-4075-A393-E11C8F1DEA74Q33974601-82DC3D21-74BC-4FB5-BDEC-7CB4D576BD06Q34306796-DC816AF7-CF1D-421F-A739-41E75A85B962Q34391750-283BD697-5D60-43C2-B3F0-10D9763B4D37Q34658608-67AD816D-DB08-4031-913B-FAD7E845E18FQ34691351-C065FCA4-102A-4DFD-AAEA-FDD72C5A879EQ34755910-ABA684EB-97A4-4433-B6E8-C6A9E269F9C4Q34797004-F251A91A-0CC7-49A0-A9C3-018530D66623Q34823344-29BFB0DE-1E6F-4DDD-8867-4BB78C3395F9Q34888756-6D9EDF57-3FA1-430E-AFA1-30E2E74755A4Q35023253-D96A6F14-1AFB-4691-B8B8-630D8BBB683FQ35024694-4F180AC6-8D54-4EC4-AF6C-309E8D058421
P2860
Structural and functional characterization of human immunodeficiency virus tat protein
description
1989 nî lūn-bûn
@nan
1989 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Structural and functional characterization of human immunodeficiency virus tat protein
@ast
Structural and functional characterization of human immunodeficiency virus tat protein
@en
Structural and functional characterization of human immunodeficiency virus tat protein
@nl
type
label
Structural and functional characterization of human immunodeficiency virus tat protein
@ast
Structural and functional characterization of human immunodeficiency virus tat protein
@en
Structural and functional characterization of human immunodeficiency virus tat protein
@nl
prefLabel
Structural and functional characterization of human immunodeficiency virus tat protein
@ast
Structural and functional characterization of human immunodeficiency virus tat protein
@en
Structural and functional characterization of human immunodeficiency virus tat protein
@nl
P2093
P2860
P3181
P1433
P1476
Structural and functional characterization of human immunodeficiency virus tat protein
@en
P2093
R Burghoff
P2860
P3181
P407
P577
1989-01-01T00:00:00Z